Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excess weight in patients with cystic fibrosis: is it always beneficial?
González Jiménez D, Muñoz-Codoceo R, Garriga-García M, Molina-Arias M, Álvarez-Beltrán M, García-Romero R, Martínez-Costa C, Meavilla-Olivas SM, Peña-Quintana LR, Gallego Gutiérrez S, Marugán de Miguelsanz JM, Suárez Cortina L, Castejón Ponce EN, Leis Trabazo R, Martín Cruz F, Díaz Martín JJ, Bousoño García C. González Jiménez D, et al. Nutr Hosp. 2017 Jun 5;34(3):578-583. doi: 10.20960/nh.620. Nutr Hosp. 2017. PMID: 28627192 Free article.
Acute cholecystitis as an adverse effect of treatment with elexacaftor/tezacaftor/ivacaftor in a patient with cystic fibrosis.
Martín de Vicente C, Cáceres Barrera SJ, Fuentes Sánchez C, Gutiérrez Alonso C, García Romero R. Martín de Vicente C, et al. Among authors: garcia romero r. An Pediatr (Engl Ed). 2024 Dec;101(6):413-414. doi: 10.1016/j.anpede.2024.11.006. Epub 2024 Dec 2. An Pediatr (Engl Ed). 2024. PMID: 39627094 Free article. No abstract available.
Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E. Germán-Díaz M, et al. Eur J Pediatr. 2024 Aug;183(8):3173-3182. doi: 10.1007/s00431-024-05577-5. Epub 2024 Apr 26. Eur J Pediatr. 2024. PMID: 38664251
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Salvador-Martín S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Torres-Peral R, Rodríguez A, Bossacoma F, Merino-Bohórquez V, Salcedo E, Álvarez R, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Biomed Pharmacother. 2024 Apr;173:116299. doi: 10.1016/j.biopha.2024.116299. Epub 2024 Feb 23. Biomed Pharmacother. 2024. PMID: 38401525 Free article.
Severe adenovirus infection: presentation of 3 cases.
Galindo García AC, Bolsa Ferrer IT, Casajús Pelegay P, García Romero R, Martín de Vicente C. Galindo García AC, et al. An Pediatr (Engl Ed). 2024 Jun;100(6):465-467. doi: 10.1016/j.anpede.2024.05.005. Epub 2024 May 28. An Pediatr (Engl Ed). 2024. PMID: 38811334 Free article. No abstract available.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Zapata-Cobo P, Salvador-Matín S, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Sánchez-Hernández JG, Rodríguez A, Bossacoma F, Balboa MJ, Salcedo E, Sanjurjo-Sáez M, López-Fernández LA. Zapata-Cobo P, et al. Pharmacol Res. 2023 Oct;196:106938. doi: 10.1016/j.phrs.2023.106938. Epub 2023 Sep 23. Pharmacol Res. 2023. PMID: 37748560 Free article. No abstract available.
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J. Pujol-Muncunill G, et al. Eur J Pediatr. 2024 Aug;183(8):3253-3262. doi: 10.1007/s00431-024-05588-2. Epub 2024 May 3. Eur J Pediatr. 2024. PMID: 38700692
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Salvador-Martín S, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Sánchez C, Tolín M, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Loverdos I, Navas López VM, Millán A, Magallares L, Torres-Peral R, García-Romero R, Pujol-Muncunill G, Merino-Bohorquez V, Rodríguez A, Salcedo E, López-Cauce B, Marín-Jiménez I, Menchén L, Laserna-Mendieta E, Lucendo AJ, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Int J Mol Sci. 2023 Jan 16;24(2):1797. doi: 10.3390/ijms24021797. Int J Mol Sci. 2023. PMID: 36675312 Free PMC article.
77 results